• ReNeuron licenses rights to its CTX and hRPC cell therapy programmes to Fosun Pharma for Chinese market.


  • ReNeuron has since its inception forged a strong network or research collaborations with academia, including institutions such as University College London and Swansea University, we continue to look for research partners who share our desire to revolutionise the treatment and diagnosis of disease.

If you would like to get in touch with our Research Organisation, please reach out here.